RHEOS
Dead / Abandoned — Abandoned — no statement of use filed (as of 21 Sept 2020)
What this means for you
This application is over — abandoned 21 Sept 2020. The name may be available, but check before relying on it — rights can also come from actual use, not only from the register.
Record
- Serial number
- 88292491
- Mark type
- Design + words
- Filed
- 07 Feb 2019
- Published for opposition
- 24 Dec 2019
- Abandoned
- 21 Sept 2020
- Attorney of record
- Douglas R. Wolf
Goods and services
- Class 005 — Pharmaceuticals: pharmaceutical preparations for the treatment of autoimmune diseases and cancer; pharmaceutical preparations that modulate immune cell metabolism
- Class 042 — Scientific and technological services: biomedical, pharmaceutical and scientific research in the field of autoimmunity and oncology; pharmaceutical drug services, namely, pharmaceutical research and development; medical and scientific research, namely, conducting clinical trials for others; product development in the field of autoimmunity and oncology; research and development of human therapeutics using cellular harnessing
Owner
- Rheos Medicines, Inc., Cambridge, MA, US
- Rheos Medicines, Inc., Cambridge, MA, US
Prior registrations
Prosecution history
- 21 Sept 2020 — ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
- 21 Sept 2020 — ABANDONMENT - NO USE STATEMENT FILED
- 18 Feb 2020 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 24 Dec 2019 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 24 Dec 2019 — PUBLISHED FOR OPPOSITION
- 04 Dec 2019 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 19 Nov 2019 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 29 Oct 2019 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 29 Oct 2019 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 25 Oct 2019 — ASSIGNED TO LIE
- 21 Oct 2019 — TEAS RESPONSE TO OFFICE ACTION RECEIVED
- 26 Apr 2019 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
- 26 Apr 2019 — NON-FINAL ACTION E-MAILED
- 26 Apr 2019 — NON-FINAL ACTION WRITTEN
- 19 Apr 2019 — ASSIGNED TO EXAMINER